Similar articles

• The problem of overuse.

  Covinsky KE. Covinsky KE. JAMA Intern Med. 2013 Aug 12;173(15):1446. doi: 10.1001/jamainternmed.2013.8421. JAMA Intern Med. 2013. PMID: 23817453 No abstract available.
• Decrease the incentives to order lipid panels.

  McConnell M, Downs JR, Good CB. McConnell M, et al. JAMA Intern Med. 2014 Mar;174(3):473. doi: 10.1001/jamainternmed.2013.12872. JAMA Intern Med. 2014. PMID: 24590082 No abstract available.
• Decrease the incentives to order lipid panels--reply.

  Virani SS, Ballantyne CM, Petersen LA. Virani SS, et al. JAMA Intern Med. 2014 Mar;174(3):473-4. doi: 10.1001/jamainternmed.2013.12842. JAMA Intern Med. 2014. PMID: 24590083 No abstract available.
• Clinical review 141: lipids and atherosclerosis: lessons learned from randomized controlled trials of lipid lowering and other relevant studies.

  Kreisberg RA, Oberman A. Kreisberg RA, et al. J Clin Endocrinol Metab. 2002 Feb;87(2):423-37. doi: 10.1210/jcem.87.2.8057. J Clin Endocrinol Metab. 2002. PMID: 11836262 Review. No abstract available.
• [Lowering LDL cholesterol. How much is enough?].

  März W, Grammer TB. März W, et al. Internist (Berl). 2007 Mar;48(3):319-26. doi: 10.1007/s00108-007-1810-4. Internist (Berl). 2007. PMID: 17333056 Review. German.